Antozyme Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 11-01-2025
- Paid Up Capital ₹ 5.10 M
as on 11-01-2025
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.27 Cr
as on 11-01-2025
- Satisfied Charges ₹ 4.00 M
as on 11-01-2025
- Revenue 346.72%
(FY 2022)
- Profit 244.36%
(FY 2022)
- Ebitda 261.65%
(FY 2022)
- Net Worth 4406.74%
(FY 2022)
- Total Assets 269.53%
(FY 2022)
About Antozyme Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹1.27 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Harshad Changani and Rinkeshkumar Patel serve as directors at the Company.
- CIN/LLPIN
U24231GJ2019PTC108365
- Company No.
108365
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Antozyme Biotech Private Limited offer?
Antozyme Biotech Private Limited offers a wide range of products and services, including Textile, Dyeing & Finishing Chemical, Textile Chemical, Flavours & Aromatics, Food Enzymes, Pharma Ingredients & Raw Materials, API (Active Pharmaceutical Ingredients), Food Additive, Soaps, Detergent Powder & Cakes, Detergent Raw Material.
Who are the key members and board of directors at Antozyme Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshad Changani  | Director | 27-May-2019 | Current |
| Rinkeshkumar Patel | Director | 27-May-2019 | Current |
Financial Performance of Antozyme Biotech.
Antozyme Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 346.72% increase. The company also saw a substantial improvement in profitability, with a 244.36% increase in profit. The company's net worth Soared by an impressive increase of 4406.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Antozyme Biotech?
In 2021, Antozyme Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Jun 2023 | ₹1.27 Cr | Open |
Others Creation Date: 26 Sep 2022 | ₹4.00 M | Satisfied |
How Many Employees Work at Antozyme Biotech?
Unlock and access historical data on people associated with Antozyme Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Antozyme Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antozyme Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
